International Flavors & Fragrances Inc. (IFF)

NYSE: IFF · Real-Time Price · USD

75.10

-2.43 (-3.13%)

At close: Jul 13, 2026, 4:00 PM EDT

73.95

-1.15 (-1.53%)

After-hours: Jul 13, 2026, 7:44 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taste Revenue	2.51B	2.48B	2.43B
Taste Revenue Growth	1.17%	2.18%	5.43%
Food Ingredients Revenue	3.32B	3.28B	3.37B
Food Ingredients Revenue Growth	1.31%	-2.58%	-8.86%
Health & Biosciences Revenue	2.34B	2.28B	2.20B
Health & Biosciences Revenue Growth	2.41%	3.63%	6.37%
Scent Revenue	2.52B	2.48B	2.44B
Scent Revenue Growth	1.49%	1.64%	1.92%
Pharma Solutions Revenue	-	369.00M	1.05B
Pharma Solutions Revenue Growth	-	-64.82%	2.84%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taste Adjusted Operating EBITDA	500.00M	478.00M	460.00M
Taste Adjusted Operating EBITDA Growth	4.60%	3.91%	20.73%
Food Ingredients Adjusted Operating EBITDA	426.00M	423.00M	408.00M
Food Ingredients Adjusted Operating EBITDA Growth	0.71%	3.68%	17.92%
Health & Biosciences Adjusted Operating EBITDA	609.00M	594.00M	577.00M
Health & Biosciences Adjusted Operating EBITDA Growth	2.53%	2.95%	10.12%
Scent Adjusted Operating EBITDA	519.00M	515.00M	545.00M
Scent Adjusted Operating EBITDA Growth	0.78%	-5.50%	21.11%
Pharma Solutions Adjusted Operating EBITDA	-	76.00M	215.00M
Pharma Solutions Adjusted Operating EBITDA Growth	-	-64.65%	6.44%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Nourish Capital Expenditures	322.00M	235.00M
Nourish Capital Expenditures Growth	37.02%	-6.75%
Health & Biosciences Capital Expenditures	145.00M	73.00M
Health & Biosciences Capital Expenditures Growth	98.63%	-14.12%
Scent Capital Expenditures	89.00M	70.00M
Scent Capital Expenditures Growth	27.14%	12.90%
Pharma Solutions Capital Expenditures	38.00M	85.00M
Pharma Solutions Capital Expenditures Growth	-55.29%	-18.27%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taste - Comparable Currency Neutral Sales Growth	4.00%	-
Food Ingredients - Comparable Currency Neutral Sales Growth	-3.00%	-
Health & Biosciences - Comparable Currency Neutral Sales Growth	3.00%	8.00%
Scent - Comparable Currency Neutral Sales Growth	3.00%	12.00%
Pharma Solutions - Comparable Currency Neutral Sales Growth	12.00%	2.00%
Consolidated Comparable Currency Neutral Sales Growth	2.00%	6.00%